Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 285.40
-0.60 (-0.21%)
Aug 28, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 60.19 billion as of August 28, 2026. Its market cap has increased by 15.52% in one year.
Market Cap
60.19B
Enterprise Value
79.05B
Revenue
24.63B
Ranking
n/a
PE Ratio
24.86
Stock Price
285.40
ChartMarket Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 60.19B, an increase of 2,740.59%. That is a compound annual growth rate of 11.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 60.19B | 31.30% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 128.72B |
| Coloplast | 104.19B |
| ALK-Abelló | 47.08B |
| H. Lundbeck | 41.38B |
| Zealand Pharma | 21.31B |
| Ambu A/S | 18.60B |
| Bavarian Nordic | 16.15B |